SGS, a bio/pharmaceutical analytical and bioanalytical contract solutions provider, is now offering clients large molecule bioanalytical services at its laboratory in Wavre, Belgium
The facility has invested in new and dedicated LC/MS-MS instruments and is currently validating internal methods within the laboratory, ensuring that services will be available by the end of 2017.
The investment includes the installation of Sciex instruments and the introduction of supporting Sciex BioBA sample preparation kits.
This will allow the laboratory to handle the analysis of a wide range of samples, including peptides, proteins and complex biological molecules, such as monoclonal antibodies.
Initially, the service will focus on pre-clinical samples, with the aim of rapidly expanding this to analytical methods used for clinical studies.
Bernard Jeanbaptiste, Bioanalysis Manager for SGS Belgium, said: “Our laboratory at Wavre has a rich history and expertise in small molecule analysis and the use of LC/MS-MS techniques. As a result, this investment is a natural progression of our capabilities, enabling us to serve the growing market for large molecule analysis and characterisation.”
“The investment will bring value to clients and support our current activities in large molecule bioanalysis across the global SGS network.”
SGS’s Wavre 8400 m2 laboratory, on the outskirts of Brussels, provides a wide range of services to clients around the world, including method development and validation, analytical chemistry, microbiological testing, potency assays and cell line characterisation.
With 20 laboratories offering contract analytical and bioanalytical services, SGS leverages its wholly-owned global network, present in North America, Europe, and Asia, to deliver harmonised solutions to large pharmaceutical and biotechnology firms.
In addition to testing services for the bio/pharmaceutical market, SGS also provides Phase I-IV clinical trial management and services, encompassing data management and statistics, PK/PD modelling and simulation, pharmacovigilance and regulatory consultancy.
In Europe, the integrated SGS laboratory network contains several specialist service centres providing support for the testing requirements associated with small and large molecule development, including characterisation of large molecules and bioanalysis.